SV2011003962A - Compuestos etanaminicos y su uso para tratar la depresion - Google Patents

Compuestos etanaminicos y su uso para tratar la depresion

Info

Publication number
SV2011003962A
SV2011003962A SV2011003962A SV2011003962A SV2011003962A SV 2011003962 A SV2011003962 A SV 2011003962A SV 2011003962 A SV2011003962 A SV 2011003962A SV 2011003962 A SV2011003962 A SV 2011003962A SV 2011003962 A SV2011003962 A SV 2011003962A
Authority
SV
El Salvador
Prior art keywords
ethanaminal
compounds
treat depression
piridin
amina
Prior art date
Application number
SV2011003962A
Other languages
English (en)
Inventor
Micahel Balestra
Peter Bernstein
Glen E Ernst
William Frietze
John P Mccauley
David Nugiel
Lihong Shen
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42288011&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SV2011003962(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of SV2011003962A publication Critical patent/SV2011003962A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/15—Fumaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Confectionery (AREA)

Abstract

COMPUESTOS ETANAMÍNICOS, A SABER, 1-(3-FLUOROFENIL)-2-METIL-2- (PIRIDIN-2-IL)PROPAN-1-AMINA Y 2-METIL-1-FENIL-2-(PIRIDIN-2-IL)PROPAN-1-AMINA, SUS SALES Y ENANTIÓMEROS, Y SU USO PARA TRATAR LA DEPRESIÓN
SV2011003962A 2008-12-24 2011-06-24 Compuestos etanaminicos y su uso para tratar la depresion SV2011003962A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14067308P 2008-12-24 2008-12-24

Publications (1)

Publication Number Publication Date
SV2011003962A true SV2011003962A (es) 2012-01-06

Family

ID=42288011

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2011003962A SV2011003962A (es) 2008-12-24 2011-06-24 Compuestos etanaminicos y su uso para tratar la depresion

Country Status (31)

Country Link
US (4) US8013165B2 (es)
EP (2) EP2391606A4 (es)
JP (1) JP5491524B2 (es)
KR (1) KR20110097996A (es)
CN (1) CN102333762B (es)
AR (1) AR074981A1 (es)
AU (1) AU2009330745B2 (es)
BR (1) BRPI0923476A2 (es)
CA (1) CA2748235A1 (es)
CL (1) CL2011001590A1 (es)
CO (1) CO6450688A2 (es)
CR (1) CR20110365A (es)
CU (1) CU24017B1 (es)
DO (1) DOP2011000205A (es)
EA (1) EA201190064A1 (es)
EC (1) ECSP11011161A (es)
GT (1) GT201100186A (es)
HN (1) HN2011001773A (es)
IL (1) IL213518A0 (es)
MX (1) MX2011006680A (es)
NI (1) NI201100131A (es)
NZ (1) NZ593282A (es)
PE (1) PE20120249A1 (es)
SA (1) SA109310013B1 (es)
SG (2) SG192510A1 (es)
SV (1) SV2011003962A (es)
TW (1) TWI442922B (es)
UA (1) UA106056C2 (es)
UY (1) UY32360A (es)
WO (1) WO2010074647A1 (es)
ZA (1) ZA201105441B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8013165B2 (en) 2008-12-24 2011-09-06 Astrazeneca Ab Ethanamine compounds and methods of using the same 545
CN112250676B (zh) * 2020-11-24 2023-05-16 深圳市第二人民医院(深圳市转化医学研究院) 一种具有抗抑郁活性的含氧杂环化合物
CN112279843B (zh) * 2020-11-24 2023-05-16 深圳市第二人民医院(深圳市转化医学研究院) 一种具有抗抑郁活性的含氮杂环化合物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3422191A (en) 1965-01-21 1969-01-14 Synergistics Inc Compositions and methods for tranquilization employing salts of n-morpholine ethanol
GB1427026A (en) 1972-11-20 1976-03-03 Ici Ltd Synthetic film materials
JPS5756474B2 (es) 1973-05-26 1982-11-30
GB9320273D0 (en) 1993-04-01 1993-11-17 Fisons Corp Compound useful in therapy
US5455259A (en) 1987-02-06 1995-10-03 Fisons Corporation Compounds for the treatment of neurodegenerative disorders
EP0356035B1 (en) 1988-08-12 1996-03-13 Astra Aktiebolag Arylkalkyl-amines and -amides having anticonvulsant and neuroprotective properties
JP2514855B2 (ja) 1990-08-08 1996-07-10 キッセイ薬品工業株式会社 光学活性なアラニンアニリド誘導体の酸付加塩
US5206248A (en) 1992-03-27 1993-04-27 Smith Richard A Method for reducing emotional lability
WO1993009095A1 (en) * 1991-10-30 1993-05-13 Fisons Corporation 2-heterocyclicethylamine derivatives and their use as pharmaceuticals
CZ288519B6 (cs) 1992-04-03 2001-07-11 Astra Ab (S)-alfa-Fenyl-2-pyridinethanamin, způsob jeho přípravy, farmaceutická kompozice tento enantiomer obsahující, tento enantiomer pro použití jako léčivo a použití tohoto enantiomeru pro výrobu léčiva
NZ332334A (en) * 1996-04-19 2000-06-23 Akzo Nobel Nv Substituted benzylamines and their use for the treatment of depression and other neurologically related disorders
EP0869122B1 (en) 1997-03-31 2002-12-04 Korea Research Institute Of Chemical Technology Quinolinic sulfide derivatives acting as NMDA receptor antagonists and process for preparation thereof
TW544448B (en) 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
SE9901077D0 (sv) 1999-03-23 1999-03-23 Astra Ab Novel use
SE9901340D0 (sv) 1999-04-15 1999-04-15 Astra Pharma Prod Novel process
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
US8013165B2 (en) 2008-12-24 2011-09-06 Astrazeneca Ab Ethanamine compounds and methods of using the same 545

Also Published As

Publication number Publication date
US9035065B2 (en) 2015-05-19
UY32360A (es) 2010-07-30
ECSP11011161A (es) 2011-07-29
EP2391606A4 (en) 2012-06-13
EA201190064A1 (ru) 2012-02-28
AU2009330745B2 (en) 2012-04-05
SA109310013B1 (ar) 2013-07-28
IL213518A0 (en) 2011-07-31
NI201100131A (es) 2012-03-19
CO6450688A2 (es) 2012-05-31
BRPI0923476A2 (pt) 2016-01-19
US20130137731A1 (en) 2013-05-30
DOP2011000205A (es) 2011-07-15
US8013165B2 (en) 2011-09-06
CU24017B1 (es) 2014-07-30
EP2391606A1 (en) 2011-12-07
CN102333762A (zh) 2012-01-25
JP5491524B2 (ja) 2014-05-14
AU2009330745A1 (en) 2011-08-04
GT201100186A (es) 2013-10-08
KR20110097996A (ko) 2011-08-31
JP2012513993A (ja) 2012-06-21
CU20110141A7 (es) 2012-01-31
SG171928A1 (en) 2011-07-28
CA2748235A1 (en) 2010-07-01
AR074981A1 (es) 2011-03-02
CN102333762B (zh) 2014-06-11
SG192510A1 (en) 2013-08-30
UA106056C2 (uk) 2014-07-25
TW201028149A (en) 2010-08-01
HN2011001773A (es) 2014-08-18
MX2011006680A (es) 2011-07-12
NZ593282A (en) 2013-06-28
CL2011001590A1 (es) 2012-06-22
EP2610246A1 (en) 2013-07-03
PE20120249A1 (es) 2012-04-19
CR20110365A (es) 2011-08-09
WO2010074647A1 (en) 2010-07-01
US20120277272A1 (en) 2012-11-01
US20100179199A1 (en) 2010-07-15
US20120115913A1 (en) 2012-05-10
ZA201105441B (en) 2012-03-28
TWI442922B (zh) 2014-07-01

Similar Documents

Publication Publication Date Title
CL2009000063S1 (es) Mango para maquina de afeitar.
CL2009001452S1 (es) Pieza agarre cabezal de cuchillas.
CL2009001263S1 (es) Maquina de afeitar.
SV2010003593A (es) Nuevos herbicidas
CR11776A (es) Inhibidores de bace
CL2009001380S1 (es) Mango de maquina de afeitar.
DK2338116T3 (da) Dokumentbaserede arbejdsgange
UY34161A (es) 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil) carbamimidoil)pirazina-2-carboxamida, sus usos, y composiciones que la contienen
CL2011000482S1 (es) Aplicador para cuidado oral.
IT1394472B1 (it) Tavolo per riunioni.
CL2009002072S1 (es) Mango para maquina de afeitar.
BRPI0918414A2 (pt) ferramenta para guindaste
BRPI0921950A2 (pt) suporte para ferramentas
EA201270280A1 (ru) Соединения пиримидина в качестве ингибиторов при лечении туберкулеза
CL2009001363S1 (es) Pieza para maquina de afeitar.
CL2009001235A1 (es) Compuestos derivados 4-(3-alquilsulfinilbenzoil)pirazoles, composiciones herbicidas que los contine, procedimiento para reprimir plantas indeseadas, uso dichos compuestos y compuestos intermediarios.
ES2572368T3 (es) Tratamiento de la artrosis
SV2011003962A (es) Compuestos etanaminicos y su uso para tratar la depresion
UY32042A (es) Compuestos de 2-aminopirimidina como potentes inhibidores de hsp-90
CL2008001014A1 (es) Procedimiento para preparar comprimidos de dihidrocloruro de prampipexol.
CU20130044A7 (es) Proceso para la preparación de inhibidores de pan-cdk de fórmula (i), e intermediarios de la preparación
UY34170A (es) Formas cristalinas de 2,2,2-trifluoro-N-[(1R,2S)-1-[1-(4-fluorofenil)indazol-5-il]oxi-1-(3-metoxifenil)propan-2-il]acetamida
PA8851701A1 (es) Tratamiento para la glomerulonefritis
ECSP066818A (es) Proceso para la preparacion de inhibidores de triptasa
CR11654A (es) Compuestos de pirimidilmetil-sulfonamida